Key Takeaways
- Active code: The IMC Regulations, 2002 are the operative professional-conduct rules for doctors. The NMC 2023 draft remains in abeyance.
- Core prohibition: Direct or indirect patient solicitation through self-aggrandising advertising is prohibited under Clause 6.1.1.
- Highest risk: Advertising cures for conditions restricted by the Drugs and Magic Remedies Act, 1954 carries criminal liability.
- Safest posture: Factual, educational, evidence-based communication — not outcome claims or superlatives.
- Before launch: High-risk creatives should be reviewed by qualified legal counsel.
Navigating medical advertising in India means separating active statutory mandates from non-operative drafts and from marketing-agency mythmaking. Getting it wrong exposes registered medical practitioners (RMPs) to disciplinary proceedings before State Medical Councils, and exposes healthcare brands to civil and — in one case — criminal liability.
This guide sets out the position as of July 2026, with every material claim tied to a primary source.
01 The operative code: IMC Regulations, 2002
Despite continued reporting on the NMC Registered Medical Practitioner (Professional Conduct) Regulations, 2023 (notified 2 August 2023), those regulations are not in force.
By Gazette amendment dated 23 August 2023 — the NMC Registered Medical Practitioner (Professional Conduct) (Amendment) Regulation, 2023, listed as Item 1.1 under EMRB–Ethics on the NMC Rules & Regulations index — the National Medical Commission placed the 2023 regulations in abeyance and adopted the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 as effective with immediate effect, under powers vested by the NMC Act, 2019. No later Gazette notification lifting the abeyance has been published.
6.1.1 Soliciting of patients directly or indirectly, by a physician, by a group of physicians or by institutions or organisations is unethical. A physician shall not make use of him / her (or his / her name) as subject of any form or manner of advertising or publicity through any mode either alone or in conjunction with others which is of such a character as to invite attention to him or to his professional position, skill, qualification, achievements, attainments, specialties, appointments, associations, affiliations or honours and/or of such character as would ordinarily result in his self aggrandizement.
02 The five governing instruments
Medical marketing in India is not governed by the medical council alone. A compliant campaign has to satisfy five distinct frameworks at once.
| Instrument & citation | Scope | Enforcement / risk | Authority |
|---|---|---|---|
| IMC Regulations, 2002 Ch. 6 · Cl. 6.1, 6.4 | Soliciting, self-aggrandisement, commercial endorsements, fee-splitting by or involving RMPs. |
Disciplinary Warning, suspension, or erasure from the register. |
NMC & State Medical Councils |
| Drugs & Magic Remedies Act, 1954 Sec. 3, 4, 7 & Schedule | Advertisements suggesting the diagnosis, cure, or prevention of restricted conditions, and certain reproductive / sexual-health claims. |
Criminal Imprisonment up to 6 months (first offence), up to 1 year (subsequent) plus fine (Sec. 7). |
Judicial Magistrates / State Drug Controllers |
| Consumer Protection Act, 2019 Sec. 21 · CCPA Guidelines 2022 | Misleading advertisements, false or unverified outcome claims, deceptive endorsements. |
Civil CCPA may order discontinuation or modification, impose penalties, and restrain endorsers. |
Central Consumer Protection Authority |
| DPDP Act, 2023 Digital Personal Data Protection | Consent for patient data collected via lead forms, WhatsApp flows, and testimonial capture. |
Civil Financial penalties for unlawful processing or breaches, as the framework is operationalised. |
Data Protection Board of India |
| ASCI Code Self-regulatory | Truthfulness, substantiation, and non-exaggeration in advertising content. |
Advisory Recommendations issued; non-compliance referred to statutory regulators. |
Advertising Standards Council of India |
Enforcement of the DMR Act has tightened: in Indian Medical Association v. Union of India (2025), the Supreme Court issued directions to State Governments for stricter implementation against misleading medical and cure-claim advertisements. Confirm the current citation before relying on it.
03 What is prohibited & permitted
Because the 2023 draft is in abeyance, campaigns are measured against the IMC Regulations, 2002. Clause 6.1.1 names institutions and organisations alongside individual physicians, so institutional marketing is held to the same underlying standard.
Strictly prohibited
- Soliciting patients, directly or indirectly Paid campaigns built around a doctor's profile, skill, or achievements to drive patient volume. IMC 2002 · Cl. 6.1.1
- Commercial product endorsements RMPs endorsing or certifying drugs, apparatus, or commercial healthcare products. IMC 2002 · Cl. 6.1.1
- Advertising restricted conditions Ads suggesting cure or treatment of Schedule conditions (e.g. cancer, diabetes, epilepsy, heart disease), or of conception, sexual capacity, or menstrual disorders. DMR Act 1954 · Sec. 3
- Superlatives & guarantees "No. 1", "Best", "100% cure", "painless", "guaranteed" — with or without evidence. IMC 2002 · Cl. 6.1.1 · CPA 2019
- Rebates, fee-splitting & touting Per-lead or per-patient commissions paid to agencies or aggregators. IMC 2002 · Cl. 6.4.1
Permitted
- Factual press announcements Starting practice, change of practice type or address, temporary absence, resumption, or public declaration of charges. IMC 2002 · Cl. 6.1.1
- Public health education Articles and lectures on general hygiene, disease awareness, and public health — provided they don't solicit practice or self-promote. IMC 2002 · General duties
- Factual institutional information Clinic name, specialties, facilities, timings, registration details, and fee schedules, without individual self-aggrandisement. Interpretation under Cl. 6.1.1
- Accurate directories & profiles Verifiable credentials, registration numbers, hours, and contact details on a website or business listing. Practical standard
The line that decides most real cases: education vs. solicitation
A reel explaining knee-replacement recovery is education. The same reel ending with "book now — limited slots this month" is solicitation. The content can be identical; the call to action is what moves it across the line. When in doubt, inform without inviting.
04 Common myths, corrected
Agencies can be "NMC-certified" for compliance.
The NMC regulates medical professionals, not marketing vendors. No "NMC agency accreditation" exists. An agency can maintain a documented internal compliance process aligned with the law — it cannot claim regulatory endorsement.
Patient reviews are covered — and banned — by Clause 6.1.2.
Clause 6.1.2 actually restricts self-promotional display (photos or unapproved designations on signboards and letterheads). The IMC 2002 rules do not specifically regulate third-party reviews. But fabricated, incentivised, or scripted testimonials with outcome claims can be treated as misleading advertising under consumer protection law.
Doctors can't maintain professional social media profiles.
With the 2023 draft in abeyance, doctors may run professional profiles. Legality turns on content, not the platform: it must stay educational and informational, and avoid touting, patient-acquisition pitches, or self-aggrandisement under Cl. 6.1.1.
A Google Business Profile is unsafe for a clinic.
A profile may carry factual information — name, address, hours, contact, services. Risk arises from promotional descriptions, unverifiable superlatives, incentivised reviews, or misleading claims, under professional ethics and consumer protection law.
05 Pre-launch compliance checklist
Before any campaign or channel goes live
A working checklist for marketing teams and reviewers.
- No superlatives — free of "Best", "No. 1", or unsubstantiated ranking claims.
- No guaranteed outcomes — no "100% cure", "painless", or "zero risk".
- No restricted conditions — no cure or treatment claims for Sec. 3 / Schedule conditions.
- Genuine reviews only — organic and unscripted, with no outcome promises.
- Accurate credentials — names, qualifications, and SMC registration numbers verified.
- Evidence-based content — educational claims reflect current medical consensus.
- Consent captured — lead forms state data-processing terms under DPDP 2023.
- Legal review — high-risk creatives signed off by counsel.
06 Frequently asked questions
Is healthcare advertising legal in India?
Are the NMC 2023 Professional Conduct Regulations in force?
Can doctors advertise in India?
Can hospitals run paid advertising campaigns?
Can doctors use Instagram or social media professionally?
Are patient testimonials legal?
Can a doctor or clinic claim to be "India's Best" or "No. 1"?
Can marketing agencies generate leads on a commission basis?
07 Primary sources
Official statutory references
- IMC (Professional Conduct, Etiquette and Ethics) Regulations, 2002. National Medical Commission — nmc.org.in/rules-regulations/code-of-medical-ethics-regulations-2002
- Abeyance amendment (23 Aug 2023) & Rules index. National Medical Commission — nmc.org.in/rules-regulations-nmc (Item 1.1, EMRB–Ethics)
- Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. India Code — indiacode.nic.in — Act 21 of 1954 (PDF)
- Consumer Protection Act, 2019 & CCPA Guidelines, 2022. India Code / Central Consumer Protection Authority — indiacode.nic.in
- Digital Personal Data Protection Act, 2023. Ministry of Electronics & Information Technology — meity.gov.in
Stay updated
Healthcare advertising rules in India continue to evolve through statutory amendments, regulatory notifications, and judicial decisions. DoubleSure Insights reviews this guide periodically and updates it whenever a change materially affects healthcare marketing compliance — including any future Gazette notification that lifts the abeyance on the 2023 regulations.